Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (53)
Journal Articles (11)

Journal

Investigative Ophthalmology & Visual Science (64)

Article Type

ARVO Annual Meeting Abstract (53)
Retinal Cell Biology (7)
Biochemistry and Molecular Biology (2)
Retina (2)

Topics

Immunology and Microbiology (8)
Eye Anatomy and Disorders (7)
Genetics (7)
Retina (7)
Retinal Cell Biology (7)
Biochemistry and Molecular Biology (6)
Visual Neuroscience (3)
Pharmacology (2)
Eye Injuries / Ocular Trauma (1)
Imaging (1)
Retinal Imaging (1)

Tags

cytokine (4)
endothelial cells (4)
retina (4)
docosahexaenoic acids (3)
glucose (3)
proteins (3)
rna, messenger (3)
cell adhesion molecules (2)
diabetes mellitus (2)
fatty acids (2)

Specify Date Range

From: To: Apply

Showing 1 – 20 of 64

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Anti-ceramide immunotherapy for diabetic retinopathy

Tim Florian Dorweiler; Peter Nolan; Richard N. Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):459. doi:

ARVO Annual Meeting Abstract June 2022

Correction of diabetic retinopathy by mitochondrial transfer

Denis A Proshlyakov; Sandra S Hammer; Sergio Li Calzi; Tim Florian Dorweiler; Cristiano P. Vieira; Kiera Fisher; Shari Atilano; M.Cristina Kenney; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):791 – F0350. doi:

ARVO Annual Meeting Abstract June 2022

Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy.

Sandra S Hammer; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):782 – F0341. doi:

ARVO Annual Meeting Abstract June 2022

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maria B Grant; Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2310. doi:

ARVO Annual Meeting Abstract June 2022

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Sandra S Hammer; Cristiano P. Vieira; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Ram Prasad; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3591 – A0046. doi:

ARVO Annual Meeting Abstract June 2021

Statins and α cyclodextrin treatments prevent cholesterol crystal-induced pathology in human retinal endothelial cells and in db/db mice.

Sandra S Hammer; Delaney McFarland; George Abela; Sergio Li Calzi; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2928. doi:

ARVO Annual Meeting Abstract June 2021

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1106. doi:

ARVO Annual Meeting Abstract July 2019

Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy

Koushik Mondal; Todd Lydic; Rajashekhar Gangaraju; Julia V Busik; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2681. doi:

ARVO Annual Meeting Abstract July 2019

EFFECT OF SERUM STARVATION ON THE SIRT1-LXR SIGNALING PATHWAY IN RETINAL ENDOTHELIAL CELLS

Maximilian Sandler; Sandra S Hammer; Delaney Marie McFarland; Elahe Crockett-Torabi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2702. doi:

ARVO Annual Meeting Abstract July 2019

Control of retinal cholesterol levels by fasting-induced activation of SIRT1-LXR pathway in diabetic retinopathy.

Delaney McFarland; Sandra S Hammer; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2704. doi:

ARVO Annual Meeting Abstract July 2019

SPHINGOLIPID METABOLISM CONTRIBUTES TO MITOCHONDRIAL DYSFUNCTON INDUCED BY DIABETOGENIC CONDITION IN RETINAL EPITHELIAL CELLS

Kiera Fisher; Yan Levitsky; Sandra S Hammer; Todd Lydic; David Pegouske; Denis Proshlyakov; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2706. doi:

ARVO Annual Meeting Abstract July 2019

Ceramide-Induced Mitochondrial Changes in Retinal Endothelial Cells

Yan Levitsky; Sandra S Hammer; Todd Lydic; David Pegouske; Kiera Fisher; Denis Proshlyakov; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2707. doi:

ARVO Annual Meeting Abstract July 2019

THE ROLE OF THE SIRT1/LXR SIGNALING AXIS IN RETINAL ENDOTHELIAL CELL INFLAMMATION AND METABOLISM.

Sandra S Hammer; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2728. doi:

ARVO Annual Meeting Abstract July 2019

Targeting LXR using N,N-dimethyl-3ß-hydroxycholenamide (DMHCA) provides protection from development of diabetic retinopathy in db/db mice

Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Sergio L Calzi; Bright Asare-Bediako; Mariana Dupont; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2788. doi:

ARVO Annual Meeting Abstract July 2018

Very long chain ceramides production mediated by ELOVL4 stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability

Julia V Busik; Nermin Kady; Xuwen Liu; Todd Lydic; Sergey S Seregin; Andrea Amalfitano; Vince A Chiodo; Sanford L Boye; William W Hauswirth; David A Antonetti

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3002. doi:

ARVO Annual Meeting Abstract July 2018

Activation of Liver X Receptor Reverses Decrease in Cholesterol Efflux in Diabetic Retinal Endothelial Cells.

Mercedes Elizabeth Serratos; Sandra S Hammer; Delaney Marie McFarland; Elahé Crockett; Maria Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3556. doi:

ARVO Annual Meeting Abstract July 2018

Long-term intermittent fasting prevents development of diabetic retinopathy and is associated with an increase in tauroursodeoxycholate (TUDCA) in db/db mice

Cristiano Pedrozo Vieira; Eleni Beli; Leni Moldovan; Yaqian Duan; Julia V Busik; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5350. doi:

ARVO Annual Meeting Abstract July 2018

Intermittent Fasting (IF) Prevents Development of Diabetic Retinopathy (DR) by regulating low-grade inflammation through changes in lipid metaobolism

Eleni Beli; Leni Moldovan; Yaqian Duan; Sergio Li Calzi; Carmella Evans-Molina; Julia V Busik; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6002. doi:

ARVO Annual Meeting Abstract July 2018

Ceramide-induced Mitochondrial Damage in Diabetic Retinopathy

Yan Levitsky; Sandra S Hammer; Todd Lydic; Artem Muchnik; Anand Saripalli; Philip Kirschner; David Pegouske; Denis Proshlyakov; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6071. doi:

ARVO Annual Meeting Abstract July 2018

Immunoglobulin Laden Exosomes Induce Complement Activation and Membrane Attack Complex (MAC) Formation in Retinal Endothelial Cells in Diabetes

Chao Huang; Kiera Fisher; Sandra S Hammer; Gary J Blanchard; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3558. doi:

« Previous

1 2 3 4

Next 20 Results »

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept